LINC01194 and plasma cell myeloma: Additional unique characteristics were (1) a low baseline titer of antimeasles antibodies; (2) high baseline counts of both measles-reactive and tumor antigen-reactive T cells, and (3) a high mutational burden compared with 664 MM patients whose exome data are publicly available in the Multiple Myeloma Research Foundation CoMMpass Database (NCT 01454297) (Fig. 3c).